About Windtree Therapeutics
Windtree Therapeutics is a company based in Philadelphia (United States) founded in 1992.. Windtree Therapeutics has raised $44.98 thousand across 16 funding rounds from investors including HHS and Lee’s PHARM. The company has 14 employees as of December 31, 2024. Windtree Therapeutics has completed 2 acquisitions, including CommLoan and Titan Environmental Solutions. Windtree Therapeutics offers products and services including Istaroxime, SERCA2a Activators, a PKC i Inhibitors, and Rostafuroxin. Windtree Therapeutics operates in a competitive market with competitors including aTyr Pharma, ReCode Therapeutics, GEn1E, Enterprise Therapeutics and Ikaria, among others.
- Headquarter Philadelphia, United States
- Employees 14 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Windtree Therapeutics, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-1.79 M91.19as on Dec 31, 2024
-
EBITDA
$-24.93 M-42.84as on Dec 31, 2024
-
Total Equity Funding
$44.98 K (USD)
in 16 rounds
-
Latest Funding Round
$253.33 K (USD), Post-IPO
Jul 04, 2025
-
Investors
HHS
& 1 more
-
Employee Count
14
as on Dec 31, 2024
-
Investments & Acquisitions
CommLoan
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Windtree Therapeutics
Windtree Therapeutics is a publicly listed company on the OTC with ticker symbol WINT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Windtree Therapeutics
Windtree Therapeutics offers a comprehensive portfolio of products and services, including Istaroxime, SERCA2a Activators, a PKC i Inhibitors, and Rostafuroxin. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Therapy that improves heart function through dual mechanisms.
Compounds activating SERCA2a for chronic heart failure management.
Inhibitors targeting enzymes for potential heart disease treatments.
Drug for addressing specific cardiovascular conditions.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Windtree Therapeutics
Windtree Therapeutics has successfully raised a total of $44.98K across 16 strategic funding rounds. The most recent funding activity was a Post-IPO round of $253.33 thousand completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 16
- Last Round Post-IPO — $253,333
-
First Round
First Round
(13 Dec 2010)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Post-IPO - Windtree Therapeutics | Valuation |
investors |
|
| Dec, 2019 | Amount | Post-IPO - Windtree Therapeutics | Valuation |
investors |
|
| Dec, 2018 | Amount | Post-IPO - Windtree Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Windtree Therapeutics
Windtree Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Lee’s PHARM. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Innovative biopharmaceutical products are developed to address unmet medical needs.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Windtree Therapeutics
Windtree Therapeutics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CommLoan and Titan Environmental Solutions. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Waste reduction, collection, recycling, and technology solutions are provided.
|
2016 | ||||
|
Business loans are matched online between borrowers and lenders.
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Windtree Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Windtree Therapeutics Comparisons
Competitors of Windtree Therapeutics
Windtree Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as aTyr Pharma, ReCode Therapeutics, GEn1E, Enterprise Therapeutics and Ikaria, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein biologics are developed for treating rare diseases.
|
|
| domain | founded_year | HQ Location |
Precision medicines for lung-related diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of inflammatory and rare diseases
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of respiratory diseases such as cystic fibrosis
|
|
| domain | founded_year | HQ Location |
Therapies for respiratory-related cardiopulmonary disorders are developed.
|
|
| domain | founded_year | HQ Location |
Respiratory disease drugs for asthma and COPD are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Windtree Therapeutics
Frequently Asked Questions about Windtree Therapeutics
When was Windtree Therapeutics founded?
Windtree Therapeutics was founded in 1992 and raised its 1st funding round 18 years after it was founded.
Where is Windtree Therapeutics located?
Windtree Therapeutics is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Is Windtree Therapeutics a funded company?
Windtree Therapeutics is a funded company, having raised a total of $44.98K across 16 funding rounds to date. The company's 1st funding round was a Post-IPO of $39M, raised on Dec 13, 2010.
How many employees does Windtree Therapeutics have?
As of Dec 31, 2024, the latest employee count at Windtree Therapeutics is 14.
What does Windtree Therapeutics do?
Windtree Therapeutics was founded in 1992 as a biotechnology firm based in Philadelphia, United States. Focus is placed on KL4 surfactant technologies that mimic human pulmonary surfactant for treating respiratory conditions. Drug-delivery methods are explored for aerosolized administration. The pipeline features aerosurf in phase 2 trials for respiratory distress syndrome, alongside preclinical work on aerosolized KL4 for viral, radiation, and chemical lung injuries.
Who are the top competitors of Windtree Therapeutics?
Windtree Therapeutics's top competitors include aTyr Pharma, ReCode Therapeutics and Pulmatrix.
What products or services does Windtree Therapeutics offer?
Windtree Therapeutics offers Istaroxime, SERCA2a Activators, a PKC i Inhibitors, and Rostafuroxin.
Is Windtree Therapeutics publicly traded?
Yes, Windtree Therapeutics is publicly traded on OTC under the ticker symbol WINT.
How many acquisitions has Windtree Therapeutics made?
Windtree Therapeutics has made 2 acquisitions, including CommLoan, and Titan Environmental Solutions.
Who are Windtree Therapeutics's investors?
Windtree Therapeutics has 2 investors. Key investors include HHS, and Lee’s PHARM.
What is Windtree Therapeutics's ticker symbol?
The ticker symbol of Windtree Therapeutics is WINT on OTC.